Official Tittle:  Value -based Formulary -Essentials: Testing and Expanding on Value in Prescription 
Drug Benefit Design   
NCT Number: [NCT ID not yet assigned]   
Unique Protocol ID:  218066  
Document Date:  5/14/21  
  
Aim 1 Statistical Analysis Plan  
 
Aim 1: Assess  impact of VBF -e on the use of medications .  
 
Study Design:  Difference in Differences  
 
Study Period:  Jan 1st, 201 5 â€“ December  31st, 2019 
 
Unit of Analysis:  per member month  
 
Analytic Sample:  Premera  Blue Cross beneficiaries less than 65 years of age  
 
Censoring Events:   
 
Month at which an i ndividual:  
â€¢ disenroll ed for more than 1 month  during study period  
â€¢ turn ed 65 years of age  
Administrative censoring  at: 
â€¢ end of study period (December 31st, 2019)  
Administrative left truncation at:   
â€¢ 24 months prior to index date  
 
Exclusion criteri a:  
 
Exclude individuals with : 
â€¢ missing gender information   
â€¢ missing zip code level demographics  at all member months  
 
Inclusion criteria:   
 
Individuals : 
â€¢ aged 0 -64 
â€¢ Continuously enrolled in an employer -sponsored health plan for at least 12 months (with one -
month allowable gap) prior to the index date  
o For individuals in the exposed group, the index date is defined as the start date of value -
based formulary implementati on at the employer group level  
o For individuals in the control group, the index date is defined as the index date of the 
matched exposed individual  
Employer groups :  
â€¢ that transition to the value -based formulary if they transitioned  all enrollees in that employer 
group (no individual selection)  
 
Outcomes:   
 
Primary outcome (s): change in area under the curve one year after index date  for all outcomes  
Secondary outcome (s): change in area under the curve [ADDRESS_608110] :  
  Days supply of medications.  
 
Exposure: VBF-E4 and non -VBF-E4 
 
Covariates:  
 
Adjustment variables:   
 
Covariates  Time of 
Measurement  Notes  Specification  
Gender  Month before E4 
transition = index 
time   Indicator  
Age Index time  Centered  Continuous  
Relationship to contract 
holder  Index time   Categorical  
â€¢ Contract Holder ,  
â€¢ Dependent ,  
â€¢ Spouse/Domestic 
Partner)  
ACS  Index time (or 
closest to this)  For individuals with 
missing ACS variables at 
index time, set to 
closest observed value .  Quintile  
   Percent 25 years old 
or older with     
   a bachelorâ€™s degree    Quintile  
   Median household 
income    Quintile  
   Population size    Quintile  
   Percent White    Quintile  
Funding Type  Index time   Categorical   
(self, full)  
Elixhauser  12 months prior to 
transition time   Categorical variable  
â€¢ 0 
â€¢ 1 
â€¢ >=2 
Time from index date  At all observations  0 = index time, 1 = E4 
transition month  Continuous  
(-23 to 36)  
Post  At all observations  Indicator for post 
period  indicator  
Seasonality  At all observations  Adjust for calendar year 
and separately adjust 
for calendar month  Categorical (1 through 12 
for elig_mth) and (2015 
through 2019 for elig_yr)   
 
  
Effect Modifiers:  None .  
  
Exploratory Data Analysis:    
â–ª Plot outcomes across time across all index times  
â–ª 12-month enrollment for patient member months  
â–ª Histogram of age  
â–ª Univariate statistics, bivariate  
â–ª Conduct a Table 1  
â–ª Loss to follow -up 
 
Statistical Analyses:  
 
We will use a DID approach1,[ADDRESS_608111] of the E4 transition via changes in outcomes.  Time will be anchored at the month 
prior to the transition  (e.g., index time is set to the month prior to the transition) for the E4 group. Each 
of the E4 transition members will be matched to two controls via propensity score methods. Non -E4 
transition members will be  assigned to an index date corresponding to their E4 transition match. We will 
not adjust for the matching in  our models3.   
To match controls to E4 members, we will mode l the propensity score based on covariates we believe 
may be related to exposure: Gender, ACS Population Size, ACS Household Income in past 12 months, 
ACS Percent 25 years and older with a Bachel or's degree, ACS Percent White, and Year of birth. Then, we 
will obtain the log odds (logit) of the fitted values (e.g., estimates) of the propensity score for everyone 
(both E4 and possible controls) and order the log odds of the treatment (E4) group from  largest to 
smallest (in decreasing order). For each E4 member, we will find  the two nearest neighbor controls, e.g., 
the controls with the closest propensity score to that of the E4 individual with 12 months of continuous 
prior enrollment at the E4 individual's index date. After completing matching, we  will check for covariate 
balance across groups based on the standardized mean differences and Kolmogorov â€“Smirnov statistic .  
 
To address the zero -inflated and right skewed nature of the outcomes, we will use a two part -model. In 
the first stage of the two -part model, we will estimat e the probability of the response being greater than 
zero and in the second stage we will model the non -zero portion. We will choose the most appropriate 
mean -variance relationship by [CONTACT_474545] -of-fit tests (Pearsonâ€™s correlation, Pregibon link, 
modified Park, and modified Hosmer -Lemeshow tests)4,5 on the outcome s. We will assume  
independence in the mean modeling to estimate the area under the curve change at 1 (primary), [ADDRESS_608112] errors that account for repeated 
measurements within an individual (clustering on the individual level) . We will adjust for individual -level 
(age, gender, and Elixhauser comorbidity score) and census ZIP -code level characteristics (educational 
attainment, median household income, race/ethnicity and urban residence) in all models.  
 
Model:  
 
Denote spending for member i at time t as ğ‘¦ğ‘–ğ‘¡, with ğ‘–âˆˆ{1,â€¦,ğ‘}, ğ‘¡âˆˆ{âˆ’ 23,â€¦,0,â€¦,36}, and N the 
number of members . Let M be the number of covariates included in the model  and ğ‘¥ğ‘š,ğ‘–ğ‘¡ denote the 
ğ‘šthcovariate for member i at m onth  t. 
 
Then the two -stage model is:  
ğ‘ğ‘–ğ‘¡âˆ¼ğµğ‘’ğ‘Ÿğ‘›ğ‘œğ‘¢ğ‘™ğ‘™ğ‘–  (ğœƒğ‘–ğ‘¡), 
logit (ğœƒğ‘–ğ‘¡)=ğ›¼0+ âˆ‘ ğ›¼ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡,  
(ğ‘¦ğ‘–ğ‘¡ | ğ‘¦ğ‘–ğ‘¡>0)âˆ¼ğ‘ƒğ‘œğ‘–ğ‘ ğ‘ ğ‘œğ‘›  (ğœ‡ğ‘–ğ‘¡), and 
ğœ‡ğ‘–ğ‘¡= ğ¸(ğ‘¦ğ‘–ğ‘¡ | ğ‘¦ğ‘–ğ‘¡>0,ğ‘‹ğ‘–), 
where  ğ‘‹ğ‘– is the matrix for all observed covariates for member i. We model the mean, ğœ‡ğ‘–ğ‘¡, as 
log (ğœ‡ğ‘–ğ‘¡)=ğ›½0+ âˆ‘ ğ›½ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡. 
We suppose,  
âˆ‘ğ›¼ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡=ğ›¼1ğ¸4ğ‘–+ğ›¼2ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›¼3ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›¼4ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›¼5ğ¸4ğ‘–âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ 
         ğ›¼6ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›¼7ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›¼8ğ´ğ‘”ğ‘’ ğ‘–+ 
                 ğ›¼9ğºğ‘’ğ‘›ğ‘‘ğ‘’ğ‘Ÿ ğ‘–+ğ›¼10ğ¸ğ‘™ğ‘–ğ‘¥ â„ğ‘ğ‘¢ğ‘ ğ‘’ğ‘Ÿ ğ‘–+ğ›¼11ğ‘…ğ‘’ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘›ğ‘  â„ğ‘–ğ‘ğ‘–+                
  ğ›¼12ğ¹ğ‘¢ğ‘›ğ‘‘ğ‘–ğ‘›ğ‘”ğ‘‡ğ‘¦ğ‘ğ‘’ ğ‘–+ğ›¼13ğ´ğ¶ğ‘†ğ‘ƒğ‘œğ‘ğ‘¢ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘–+ğ›¼14ğ´ğ¶ğ‘† ğ¼ğ‘›ğ‘ğ‘œğ‘šğ‘’ ğ‘–+ 
  ğ›¼15ğ´ğ¶ğ‘†ğ‘ƒğ‘’ğ‘Ÿğ‘ğ‘’ğ‘›ğ‘¡ğ‘Š â„ğ‘–ğ‘¡ğ‘’ğ‘–+ğ›¼16ğ´ğ¶ğ‘†ğ¸ğ‘‘ğ‘¢ğ‘ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– ,                  
and 
âˆ‘ ğ›½ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘—ğ‘¡=ğ›½1ğ¸4ğ‘–+ğ›½2ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›½3ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›½4ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ğ‘–ğ‘¡+ğ›½5ğ¸4ğ‘–âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ 
         ğ›½6ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›½7ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›½8ğ´ğ‘”ğ‘’ ğ‘–+ 
                 ğ›½9ğºğ‘’ğ‘›ğ‘‘ğ‘’ğ‘Ÿ ğ‘–+ğ›½10ğ¸ğ‘™ğ‘–ğ‘¥ â„ğ‘ğ‘¢ğ‘ ğ‘’ğ‘Ÿ ğ‘–+ğ›½11ğ‘…ğ‘’ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘›ğ‘  â„ğ‘–ğ‘ğ‘–+                
  ğ›½12ğ¹ğ‘¢ğ‘›ğ‘‘ğ‘–ğ‘›ğ‘”ğ‘‡ğ‘¦ğ‘ğ‘’ ğ‘–+ğ›½13ğ´ğ¶ğ‘†ğ‘ƒğ‘œğ‘ğ‘¢ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘–+ğ›½14ğ´ğ¶ğ‘† ğ¼ğ‘›ğ‘ğ‘œğ‘šğ‘’ ğ‘–+ 
  ğ›½15ğ´ğ¶ğ‘†ğ‘ƒğ‘’ğ‘Ÿğ‘ğ‘’ğ‘›ğ‘¡ğ‘Š â„ğ‘–ğ‘¡ğ‘’ğ‘–+ğ›½16ğ´ğ¶ğ‘†ğ¸ğ‘‘ğ‘¢ğ‘ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– ,                   
for member i where:  
â€¢ ğ¸4ğ‘– = indicator of whether  the ğ‘–ğ‘¡â„  member  is enrolled in VBF -E4  
â€¢ ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡ = indicator of whether the ğ‘–ğ‘¡â„  member is in the post  index period , ğ‘¡â‰¥1 
â€¢ ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡ = time in months from the ğ‘–ğ‘¡â„  members index date  
â€¢ ğ´ğ‘”ğ‘’ ğ‘– = centered age for the ğ‘–ğ‘¡â„  member at index  
â€¢ ğºğ‘’ğ‘›ğ‘‘ğ‘’ğ‘Ÿ ğ‘– = ğ‘–ğ‘¡â„ members gender at index  
â€¢ ğ¸ğ‘™ğ‘–ğ‘¥ â„ğ‘ğ‘¢ğ‘ ğ‘’ğ‘Ÿ ğ‘– = Elixhauser comorbidity score for member i at index  
â€¢ ğ‘…ğ‘’ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘›ğ‘  â„ğ‘–ğ‘ğ‘–= ğ‘–ğ‘¡â„  members r elationship to contract holder at index  
â€¢ ğ¹ğ‘¢ğ‘›ğ‘‘ğ‘–ğ‘›ğ‘”ğ‘‡ğ‘¦ğ‘ğ‘’ ğ‘–= ğ‘–ğ‘¡â„  members funding type at index  
â€¢ ğ´ğ¶ğ‘†ğ‘ƒğ‘œğ‘ğ‘¢ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– = ACS population at the zip code level for member i at index  
â€¢ ğ´ğ¶ğ‘†ğ¼ğ‘›ğ‘ğ‘œğ‘šğ‘’ ğ‘– = ACS median household income in the prior 12 months at  zip code level for 
member i at index  
â€¢ ğ´ğ¶ğ‘†ğ‘ƒğ‘’ğ‘Ÿğ‘ğ‘’ğ‘›ğ‘¡ ğ‘Šâ„ğ‘–ğ‘¡ğ‘’ğ‘– = ACS  percent of white people at  the zip code level for member i at index  
â€¢ ğ´ğ¶ğ‘†ğ¸ğ‘‘ğ‘¢ğ‘ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– = ACS percent of people 25 years or older with a Bachelorâ€™s degree in the prior 
12 months at the zip code level for member i at index  
 
Missing Data:  
 
Complete -case analyses.  
  
Aim 2 Statistical Analysis Plan  
 
Aim 2:  Assess impact of VBF -e on patient out -of-pocket spending and health plan spending for 
prescription drugs and non -drug medical care.  
 
Study Design:  Difference in Differences  
 
Study Period:  Jan 1st, 201 5 â€“ December 31st, 2019  
 
Unit of Analysis:  per member month  
 
Analytic Sample:  Premera Blue Cross beneficiaries less than 65 years of age   
 
Censoring Events:   
 
Month at which an individual:  
â€¢ disenrolled for more than 1 month during study period  
â€¢ turned 65 years of age  
Administrative censoring at:  
â€¢ end of study period (December 31st, 2019)  
Administrative left truncation at:   
â€¢ 24 months prior to index date  
 
Exclusion criteria:   
 
Exclude individuals with:  
â€¢ missing gender information   
â€¢ missing zip code level demographics at all member months  
 
Inclusion criteria:   
 
Individuals:  
â€¢ aged 0 -64 
â€¢ Continuously enrolled in an employer -sponsored health plan for at least 12 months (with one -
month allowable gap) prior to the index date  
o For individuals in the exposed group, the index date is defined as the start date of value -
based formulary implementation at the employer group level  
o For individuals in the control group, the index date is defined as the index date of the 
matched exposed i ndividual  
Employer groups:   
â€¢ that transition to the value -based formulary if they transitioned  all enrollees in that employer 
group (no individual selection)  
 
Outcomes:   
 
Primary outcome(s):  change in area under the curve one year after index date for all o utcomes  
Secondary outcome(s): change in area under the curve [ADDRESS_608113]:  
Total spending for prescription drugs  
Patient out -of-pocket spending for prescription drugs  
Health plan spending for prescription drugs  
Total healthcare spending   
Total health plan and patient spending for vision  
 
Exposure: VBF-E4 and non -VBF-E4 
 
Covariates:  
 
Adjustment variables:  
 
Covariates  Time of 
Measurement  Notes  Specification  
Gender  Month before E4 
transition = index 
time   Indicator  
Age Index time  Centered  Continuous  
Relationship to contract 
holder  Index time   Categorical  
â€¢ Contract Holder,  
â€¢ Dependent,  
â€¢ Spouse/Domestic 
Partner)  
ACS  Index time (or 
closest to this)  For individuals with 
missing ACS variables at 
index time, set to 
closest observed value.  Quintile  
   Percent 25 years old 
or older with     
   a bachelorâ€™s degree    Quintile  
   Median household 
income    Quintile  
   Population size    Quintile  
   Percent White    Quintile  
Funding Type  Index time   Categorical  
(self, full)  
Elixhauser  12 months prior to 
transition time   Categorical variable  
â€¢ 0 
â€¢ 1 
â€¢ >=2 
Time from index date  At all observations  0 = index time, 1 = E4 
transition month  Continuous  
(-23 to 36)  
Post  At all observations  Indicator for post 
period  indicator  
Seasonality  At all observations  Adjust for calendar year 
and separately adjust 
for calendar month  Categorical (1 through 12 
for elig_mth) and (2015 
through 2019 for elig_yr)  
 
  
Effect Modifiers:  None.  
  
Exploratory Data Analysis:    
â–ª Plot outcomes across time across all index times  
â–ª 12-month enrollment for patient member months  
â–ª Histogram of age  
â–ª Univariate statistics, bivariate  
â–ª Conduct a Table 1  
â–ª Loss to follow -up 
 
Statistical Analyses:  
 
We will use a DID approach1,[ADDRESS_608114] of the E4 transition via changes in outcomes. Time will be anchored at the month 
prior to the transition (e.g., index time is set to the month prior to the transiti on) for the E4 group. Each 
of the E4 transition members will be matched to two controls via propensity score methods. Non -E4 
transition members will be assigned to an index date corresponding to their E4 transition match. We will 
not adjust for the matchin g in our models3.  
To match controls to E4 members, we will model the propensity score based on covariates we believe 
may be related to exposure: Gender, ACS Population Size, ACS Household Income in past 12 months, 
ACS Percent 25 years and older with a Bac helor's degree, ACS Percent White, and Year of birth. Then, we 
will obtain the log odds (logit) of the fitted values (e.g., estimates) of the propensity score for everyone 
(both E4 and possible controls) and order the log odds of the treatment (E4) group f rom largest to 
smallest (in decreasing order). For each E4 member, we will find the two nearest neighbor controls, e.g., 
the controls with the closest propensity score to that of the E4 individual with 12 months of continuous 
prior enrollment at the E4 ind ividual's index date. After completing matching, we will check for covariate 
balance across groups based on the standardized mean differences and Kolmogorov â€“Smirnov statistic.  
 
To address the zero -inflated and right skewed nature of the cost outcomes, we will use a two part -
model. In the first stage of the two -part model, we will estimate the probability of the response being 
greater than zero and in the second stage we will model the non -zero portion. We will choose the most 
appropriate mean -variance rela tionship by [CONTACT_474545] -of-fit tests (Pearsonâ€™s correlation, 
Pregibon link, modified Park, and modified Hosmer -Lemeshow tests) 4,[ADDRESS_608115] outcome. 
We will assume independence in the mean modeling to estimate the area under the curve ch ange at 1 
(primary), [ADDRESS_608116] errors that account 
for repeated measurements within an individual (clustering on the individual level). We will adjust for 
individual -level (age, gender, and Elixhauser comorbidity score) and census ZIP -code level characteristics 
(educational attainment, median household income, race/ethnicity and urban residence) in all models.  
 
Model:  
 
Denote spending for member i at time t as ğ‘¦ğ‘–ğ‘¡, with ğ‘–âˆˆ{1,â€¦,ğ‘}, ğ‘¡âˆˆ{âˆ’ 23,â€¦,0,â€¦,36}, and N the 
number of members. Let M be the number of covariates included in the model and ğ‘¥ğ‘š,ğ‘–ğ‘¡ denote the 
ğ‘šthcovariate for member i at month t. 
 
Then the two -stage model is:  
ğ‘ğ‘–ğ‘¡âˆ¼ğµğ‘’ğ‘Ÿğ‘›ğ‘œğ‘¢ğ‘™ğ‘™ğ‘–  (ğœƒğ‘–ğ‘¡), 
ğ‘™ğ‘œğ‘”ğ‘–ğ‘¡ (ğœƒğ‘–ğ‘¡)=ğ›¼0+ âˆ‘ ğ›¼ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–,  
(ğ‘¦ğ‘–ğ‘¡ | ğ‘¦ğ‘–ğ‘¡>0)âˆ¼ğºğ‘ğ‘šğ‘šğ‘  (ğ‘,ğ‘ğ‘–ğ‘¡), 
with ğ‘ as the shape parameter and ğ‘ as the rate parameter of the Gamma distribution, and  
ğœ‡ğ‘–ğ‘¡= ğ¸(ğ‘¦ğ‘–ğ‘¡ | ğ‘¦ğ‘–ğ‘¡>0,ğ‘‹ğ‘–)= ğ‘
ğ‘ğ‘–ğ‘¡,  
where ğ‘‹ğ‘– is the matrix for all observed covariates  for member i. We model the mean, ğœ‡ğ‘–ğ‘¡, as 
log (ğœ‡ğ‘–ğ‘¡)=ğ›½0+ âˆ‘ ğ›½ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡. 
We suppose,  
âˆ‘ğ›¼ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡=ğ›¼1ğ¸4ğ‘–+ğ›¼2ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›¼3ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›¼4ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›¼5ğ¸4ğ‘–âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ 
         ğ›¼6ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›¼7ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›¼8ğ´ğ‘”ğ‘’ ğ‘–+ 
                 ğ›¼9ğºğ‘’ğ‘›ğ‘‘ğ‘’ğ‘Ÿ ğ‘–+ğ›¼10ğ¸ğ‘™ğ‘–ğ‘¥ â„ğ‘ğ‘¢ğ‘ ğ‘’ğ‘Ÿ ğ‘–+ğ›¼11ğ‘…ğ‘’ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘›ğ‘  â„ğ‘–ğ‘ğ‘–+                
  ğ›¼12ğ¹ğ‘¢ğ‘›ğ‘‘ğ‘–ğ‘›ğ‘”ğ‘‡ğ‘¦ğ‘ğ‘’ ğ‘–+ğ›¼13ğ´ğ¶ğ‘†ğ‘ƒğ‘œğ‘ğ‘¢ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘–+ğ›¼14ğ´ğ¶ğ‘† ğ¼ğ‘›ğ‘ğ‘œğ‘šğ‘’ ğ‘–+ 
  ğ›¼15ğ´ğ¶ğ‘†ğ‘ƒğ‘’ğ‘Ÿğ‘ğ‘’ğ‘›ğ‘¡ğ‘Š â„ğ‘–ğ‘¡ğ‘’ğ‘–+ğ›¼16ğ´ğ¶ğ‘†ğ¸ğ‘‘ğ‘¢ğ‘ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– ,                  
and 
âˆ‘ ğ›½ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡=ğ›½1ğ¸4ğ‘–+ğ›½2ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›½3ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›½4ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›½5ğ¸4ğ‘–âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ 
         ğ›½6ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›½7ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡â„ğ‘–ğ‘¡+ğ›½8ğ´ğ‘”ğ‘’ ğ‘–+ 
                 ğ›½9ğºğ‘’ğ‘›ğ‘‘ğ‘’ğ‘Ÿ ğ‘–+ğ›½10ğ¸ğ‘™ğ‘–ğ‘¥ â„ğ‘ğ‘¢ğ‘ ğ‘’ğ‘Ÿ ğ‘–+ğ›½11ğ‘…ğ‘’ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘›ğ‘  â„ğ‘–ğ‘ğ‘–+                
  ğ›½12ğ¹ğ‘¢ğ‘›ğ‘‘ğ‘–ğ‘›ğ‘”ğ‘‡ğ‘¦ğ‘ğ‘’ ğ‘–+ğ›½13ğ´ğ¶ğ‘†ğ‘ƒğ‘œğ‘ğ‘¢ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘–+ğ›½14ğ´ğ¶ğ‘† ğ¼ğ‘›ğ‘ğ‘œğ‘šğ‘’ ğ‘–+ 
  ğ›½15ğ´ğ¶ğ‘†ğ‘ƒğ‘’ğ‘Ÿğ‘ğ‘’ğ‘›ğ‘¡ğ‘Š â„ğ‘–ğ‘¡ğ‘’ğ‘–+ğ›½16ğ´ğ¶ğ‘†ğ¸ğ‘‘ğ‘¢ğ‘ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– ,                   
for member i where:  
â€¢ ğ¸4ğ‘– = indicator of whether the ğ‘–ğ‘¡â„  member is enrolled in VBF -E4  
â€¢ ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡ = indicator of whether the ğ‘–ğ‘¡â„  member is in the post index period, ğ‘¡â‰¥1 
â€¢ ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡ = time in months from the ğ‘–ğ‘¡â„  members index date  
â€¢ ğ´ğ‘”ğ‘’ ğ‘– = centered age for the ğ‘–ğ‘¡â„  member at index  
â€¢ ğºğ‘’ğ‘›ğ‘‘ğ‘’ğ‘Ÿ ğ‘– = ğ‘–ğ‘¡â„ members gender at index  
â€¢ ğ¸ğ‘™ğ‘–ğ‘¥ â„ğ‘ğ‘¢ğ‘ ğ‘’ğ‘Ÿ ğ‘– = Elixhauser comorbidity score for member i at index  
â€¢ ğ‘…ğ‘’ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘›ğ‘  â„ğ‘–ğ‘ğ‘–= ğ‘–ğ‘¡â„  members r elationship to contract holder at index  
â€¢ ğ¹ğ‘¢ğ‘›ğ‘‘ğ‘–ğ‘›ğ‘”ğ‘‡ğ‘¦ğ‘ğ‘’ ğ‘–= ğ‘–ğ‘¡â„  members funding type at index  
â€¢ ğ´ğ¶ğ‘†ğ‘ƒğ‘œğ‘ğ‘¢ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– = ACS population at the zip  code level for member i at index  
â€¢ ğ´ğ¶ğ‘†ğ¼ğ‘›ğ‘ğ‘œğ‘šğ‘’ ğ‘– = ACS median household income in the prior 12 months at zip code level for 
member i at index  
â€¢ ğ´ğ¶ğ‘†ğ‘ƒğ‘’ğ‘Ÿğ‘ğ‘’ğ‘›ğ‘¡ğ‘Š â„ğ‘–ğ‘¡ğ‘’ğ‘– = ACS percent of white people at the zip code level for member i at index  
â€¢ ğ´ğ¶ğ‘†ğ¸ğ‘‘ğ‘¢ğ‘ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– = ACS percent of people 25 years or older with a Bachelorâ€™s degree in the prior 
12 months at the zip code level for member i at index  
 
Missing Data:  
 
Complete -case analyses.  
  
Aim 3 Statistical Analysis Plan  
 
Aim 3:  Assess impact of VBF -e on the number of emergency department visits, number of outpatient 
visits, and number of days in hospi[INVESTIGATOR_307] .  
 
Study Design:  Difference in Differences  
 
Study Period:  Jan 1st, 201 5 â€“ December 31st, 2019  
 
Unit of Analysis:  per member month   
 
Analytic Sample:  Premera Blue Cross beneficiaries less than 65 years of age  
 
Censoring Events:   
 
Month at which an individual:  
â€¢ disenrolled for more than 1 month during study period  
â€¢ turned 65 years of age  
Administrative censoring at:  
â€¢ end of study period (December 31st, 2019)  
Administrative left truncation at:   
â€¢ 24 months prior to index date  
 
Exclusion criteria:   
 
Exclude individuals with:  
â€¢ missing gender information  
â€¢ missing zip code level demographics at all member months  
 
Inclusion criteria:   
 
Individuals:  
â€¢ aged 0 -64 
â€¢ Continuously enrolled in an employer -sponsored health plan for at least 12 months (with one -
month allowable gap) prior to the index date  
o For individuals in the exposed group, the index date is defined as the start date of value -
based formulary implementati on at the employer group level  
o For individuals in the control group, the index date is defined as the index date of the 
matched exposed individual  
Employer groups:   
â€¢ that transition to the value -based formulary if they transitioned  all enrollees in that emp loyer 
group (no individual selection)  
 
Outcomes:   
 
Primary outcome(s):  change in area under the curve one year after index date for all outcomes  
Secondary outcome(s): change in area under the curve [ADDRESS_608117]:  
Number of emergency department visits  
Number of days in hospi[INVESTIGATOR_474544]: VBF-E4 and non -VBF-E4 
 
Covariates:  
 
Adjustment variables:  
 
Covariates  Time of 
Measurement  Notes  Specification  
Gender  Month before E4 
transition = index 
time   Indicator  
Age Index time  Will be centered.  Continuous  
Relationship to contract 
holder  Index time   Categorical  
â€¢ Contract Holder,  
â€¢ Dependent,  
â€¢ Spouse/Domestic 
Partner)  
ACS  Index time (or 
closest to this)  For individuals with 
missing ACS variables at 
index time, set to 
closest observed value.  Quintile  
   Percent 25 years old 
or older with     
   a bachelorâ€™s degree    Quintile  
   Median household 
income    Quintile  
   Population size    Quintile  
   Percent White    Quintile  
Funding Type  Index time   Categorical  
(self, full)  
Elixhauser  12 months prior to 
transition time   Categorical variable  
â€¢ 0 
â€¢ 1 
â€¢ >=2 
Time from index date  At all observations  0 = index time, 1 = E4 
transition month  Continuous  
(-23 to 36)  
Post  At all observations  Indicator for post 
period  indicator  
Seasonality  At all observations  Adjust for calendar year 
and separately adjust 
for calendar month  Categorical (1 through 12 
for elig_mth) and (2015 
through 2019 for elig _yr) 
 
  
Effect Modifiers:  None.  
  
Exploratory Data Analysis:    
â–ª Plot outcomes across time across all index times  
â–ª 12-month enrollment for patient member months  
â–ª Histogram of age  
â–ª Univariate statistics, bivariate  
â–ª Conduct a Table 1  
â–ª Loss to follow -up 
 
Statistical Analyses:  
 
We will use a DID approach1,[ADDRESS_608118] of the E4 transition via changes in outcomes. Time will be anchored at the month 
prior to the transition (e.g., index time is set to the month prior to the transition) for the E4 group. Each 
of the E4 transition members wil l be matched to two controls via propensity score methods. Non -E4 
transition members will be assigned to an index date corresponding to their E4 transition match. We will 
not adjust for the matching in our models3.  
To match controls to E4 members, we will model the propensity score based on covariates we believe 
may be related to exposure: Gender, ACS Population Size, ACS Household Income in past 12 months, 
ACS Percent 25 years and older with a Bachelor's degree, ACS  Percent White, and Year of birth. Then, we 
will obtain the log odds (logit) of the fitted values (e.g., estimates) of the propensity score for everyone 
(both E4 and possible controls) and order the log odds of the treatment (E4) group from largest to 
smal lest (in decreasing order). For each E4 member, we will find the two nearest neighbor controls, e.g., 
the controls with the closest propensity score to that of the E4 individual with 12 months of continuous 
prior enrollment at the E4 individual's index dat e. After completing matching, we will check for covariate 
balance across groups based on the standardized mean differences and Kolmogorov â€“Smirnov statistic.  
 
To address the zero -inflated and right skewed nature of the outcomes, we will use a two part -mode l. In 
the first stage of the two -part model, we will estimate the probability of the response being greater than 
zero and in the second stage we will model the non -zero portion. We will choose the most appropriate 
mean -variance relationship by [CONTACT_746] g oodness -of-fit tests ( Pearsonâ€™s correlation, Pregibon link, 
modified Park, and modified Hosmer -Lemeshow tests) 4,5 on the outcomes. We will assume 
independence in the mean modeling to estimate the area under the curve change at 1 (primary), [ADDRESS_608119] errors that account for repeated 
measurements within an individual (clustering on the individual level). We will adjust for individual -level 
(age, gender, and Elixhauser comorbidity score) and c ensus ZIP -code level characteristics (educational 
attainment, median household income, race/ethnicity and urban residence) in all models.  
 
Model:  
 
Denote spending for member i at time t as ğ‘¦ğ‘–ğ‘¡, with ğ‘–âˆˆ{1,â€¦,ğ‘}, ğ‘¡âˆˆ{âˆ’ 23,â€¦,0,â€¦,36}, and N the 
number of members. Let M be the number of covariates included in the model and ğ‘¥ğ‘š,ğ‘–ğ‘¡ denote the 
ğ‘šthcovariate for member i at month t. 
 
Then the two -stage model is:  
ğ‘ğ‘–ğ‘¡âˆ¼ğµğ‘’ğ‘Ÿğ‘›ğ‘œğ‘¢ğ‘™ğ‘™ğ‘–  (ğœƒğ‘–ğ‘¡), 
logit (ğœƒğ‘–ğ‘¡)=ğ›¼0+ âˆ‘ ğ›¼ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡,  
(ğ‘¦ğ‘–ğ‘¡ | ğ‘¦ğ‘–ğ‘¡>0)âˆ¼ğ‘ƒğ‘œğ‘–ğ‘ ğ‘ ğ‘œğ‘›  (ğœ‡ğ‘–ğ‘¡), and 
ğœ‡ğ‘–ğ‘¡= ğ¸(ğ‘¦ğ‘–ğ‘¡ | ğ‘¦ğ‘–ğ‘¡>0,ğ‘‹ğ‘–), 
where  ğ‘‹ğ‘– is the matrix for all observed covariates for member i. We model the mean, ğœ‡ğ‘–ğ‘¡, as 
log (ğœ‡ğ‘–ğ‘¡)=ğ›½0+ âˆ‘ ğ›½ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡. 
We suppose,  
âˆ‘ğ›¼ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡=ğ›¼1ğ¸4ğ‘–+ğ›¼2ğ‘ğ‘œğ‘ ğ‘¡ğ‘–ğ‘¡+ğ›¼3ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›¼4ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›¼5ğ¸4ğ‘–âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ 
         ğ›¼6ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›¼7ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›¼8ğ´ğ‘”ğ‘’ ğ‘–+ 
                 ğ›¼9ğºğ‘’ğ‘›ğ‘‘ğ‘’ğ‘Ÿ ğ‘–+ğ›¼10ğ¸ğ‘™ğ‘–ğ‘¥ â„ğ‘ğ‘¢ğ‘ ğ‘’ğ‘Ÿ ğ‘–+ğ›¼11ğ‘…ğ‘’ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘›ğ‘  â„ğ‘–ğ‘ğ‘–+                
  ğ›¼12ğ¹ğ‘¢ğ‘›ğ‘‘ğ‘–ğ‘›ğ‘”ğ‘‡ğ‘¦ğ‘ğ‘’ ğ‘–+ğ›¼13ğ´ğ¶ğ‘†ğ‘ƒğ‘œğ‘ğ‘¢ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘–+ğ›¼14ğ´ğ¶ğ‘† ğ¼ğ‘›ğ‘ğ‘œğ‘šğ‘’ ğ‘–+ 
  ğ›¼15ğ´ğ¶ğ‘†ğ‘ƒğ‘’ğ‘Ÿğ‘ğ‘’ğ‘›ğ‘¡ğ‘Š â„ğ‘–ğ‘¡ğ‘’ğ‘–+ğ›¼16ğ´ğ¶ğ‘†ğ¸ğ‘‘ğ‘¢ğ‘ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– ,                  
and 
âˆ‘ ğ›½ğ‘šğ‘€
ğ‘š=1ğ‘¥ğ‘š,ğ‘–ğ‘¡=ğ›½1ğ¸4ğ‘–+ğ›½2ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›½3ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›½4ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡+ğ›½5ğ¸4ğ‘–âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ 
         ğ›½6ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›½7ğ¸4ğ‘–âˆ—ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡âˆ—ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡+ğ›½8ğ´ğ‘”ğ‘’ ğ‘–+ 
                 ğ›½9ğºğ‘’ğ‘›ğ‘‘ğ‘’ğ‘Ÿ ğ‘–+ğ›½10ğ¸ğ‘™ğ‘–ğ‘¥ â„ğ‘ğ‘¢ğ‘ ğ‘’ğ‘Ÿ ğ‘–+ğ›½11ğ‘…ğ‘’ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘›ğ‘  â„ğ‘–ğ‘ğ‘–+                
  ğ›½12ğ¹ğ‘¢ğ‘›ğ‘‘ğ‘–ğ‘›ğ‘”ğ‘‡ğ‘¦ğ‘ğ‘’ ğ‘–+ğ›½13ğ´ğ¶ğ‘†ğ‘ƒğ‘œğ‘ğ‘¢ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘–+ğ›½14ğ´ğ¶ğ‘† ğ¼ğ‘›ğ‘ğ‘œğ‘šğ‘’ ğ‘–+ 
  ğ›½15ğ´ğ¶ğ‘†ğ‘ƒğ‘’ğ‘Ÿğ‘ğ‘’ğ‘›ğ‘¡ğ‘Š â„ğ‘–ğ‘¡ğ‘’ğ‘–+ğ›½16ğ´ğ¶ğ‘†ğ¸ğ‘‘ğ‘¢ğ‘ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– ,                   
for member i where:  
â€¢ ğ¸4ğ‘– = indicator of whether the ğ‘–ğ‘¡â„  member is enrolled in VBF -E4  
â€¢ ğ‘ğ‘œğ‘ ğ‘¡ ğ‘–ğ‘¡ = indicator of whether the ğ‘–ğ‘¡â„  member is in the post index period, ğ‘¡â‰¥1 
â€¢ ğ‘šğ‘œğ‘›ğ‘¡ â„ğ‘–ğ‘¡ = time in months from the ğ‘–ğ‘¡â„  members index date  
â€¢ ğ´ğ‘”ğ‘’ ğ‘– = centered age for the ğ‘–ğ‘¡â„  member at index  
â€¢ ğºğ‘’ğ‘›ğ‘‘ğ‘’ğ‘Ÿ ğ‘– = ğ‘–ğ‘¡â„ members gender at index  
â€¢ ğ¸ğ‘™ğ‘–ğ‘¥ â„ğ‘ğ‘¢ğ‘ ğ‘’ğ‘Ÿ ğ‘– = Elixhauser comorbidity score for member i at index  
â€¢ ğ‘…ğ‘’ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘›ğ‘  â„ğ‘–ğ‘ğ‘–= ğ‘–ğ‘¡â„  members r elationship to contract holder at index  
â€¢ ğ¹ğ‘¢ğ‘›ğ‘‘ğ‘–ğ‘›ğ‘”ğ‘‡ğ‘¦ğ‘ğ‘’ ğ‘–= ğ‘–ğ‘¡â„  members funding type at index  
â€¢ ğ´ğ¶ğ‘†ğ‘ƒğ‘œğ‘ğ‘¢ğ‘™ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– = ACS population at the zip code level for member i at index  
â€¢ ğ´ğ¶ğ‘†ğ¼ğ‘›ğ‘ğ‘œğ‘šğ‘’ ğ‘– = ACS median household income in the prior 12 months at zip code level for 
member i at index  
â€¢ ğ´ğ¶ğ‘†ğ‘ƒğ‘’ğ‘Ÿğ‘ğ‘’ğ‘›ğ‘¡ ğ‘Šâ„ğ‘–ğ‘¡ğ‘’ğ‘– = ACS percent of white people at the zip code level for member i at index  
â€¢ ğ´ğ¶ğ‘†ğ¸ğ‘‘ğ‘¢ğ‘ğ‘ğ‘¡ğ‘–ğ‘œğ‘› ğ‘– = ACS percent of people 25 years or older with a Bachelorâ€™s degree in the prior 
12 months at the zip code level for member i at index  
 
Missing Data:  
 
Complete -case analyses.  
 
 
 
References  
1.  Dimick JB, Ryan AM. Methods for evaluating changes in health care policy: the 
difference -in-differences approach. JAMA. 2014;312(22):2401 -2402.  
2. Wing C, Simon K, Bello -Gomez RA. Designing difference in difference studies: best 
practices for public health  policy research. Annu Rev Public Health. 2018;39.  
3. Schafer JL, Kang J. Average causal effects from nonrandomized studies: a practical 
guide and simulated example. Psychol Methods.  2008 Dec;13(4):279 -313. doi: 
10.1037/a0014268. PMID: 19071996.  
4.  Hosmer DW, Lemeshow S. Applied logistic regression.  2nd ed. [LOCATION_001]: Wiley; 2000.  
5.  Pregibon D. Goodness of Link Tests for Generalized Linear Models. J Appl Stat. 
1980;29(1):15.  
 
 